XML 88 R59.htm IDEA: XBRL DOCUMENT v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of equity method investments (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended
Mar. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Mar. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2024
Sep. 30, 2024
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee   $ (351,706)         $ (351,706)     $ (488,175)  
Noncontrolling interest   1,575         1,575        
Revenues   225,302   $ 94,885     411,365 $ 392,475      
Loss from continuing operations   71,687   (449,151)     51,725 (510,452)      
Net loss attributable to investees   $ 139,471   $ (433,604)     129,496 (482,769)      
FRG                      
Schedule of Equity Method Investments [Line Items]                      
Current assets                     $ 871,102
Noncurrent assets                     2,889,334
Current liabilities                     569,281
Noncurrent liabilities                     2,680,178
Revenues         $ 809,717       $ 1,615,946    
Cost of revenues         511,723       1,011,402    
Loss from continuing operations         0       (1,175)    
FRG | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee                     510,977
Net loss attributable to investees         (19,256)       (118,839)    
B&W                      
Schedule of Equity Method Investments [Line Items]                      
Current assets $ 482,878   $ 482,878     $ 482,878         530,223
Noncurrent assets 236,835   236,835     236,835         274,410
Current liabilities 511,214   511,214     511,214         297,928
Noncurrent liabilities 511,015   511,015     511,015         709,823
Noncontrolling interest 495   495     495         576
Revenues     181,194   207,556   247,470 434,723      
Cost of revenues     141,133   159,075   183,176 330,627      
Loss from continuing operations     (7,763)   (15,799)   (79,081) (70,065)      
Net loss attributable to investees     (21,989)   (16,791)   (85,010) (79,515)      
B&W | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee (303,011)   (303,011)     (303,011)         (203,694)
Net loss attributable to investees     (22,007)   (16,833)   (85,072) (83,287)      
Synchronoss Technologies, Inc.                      
Schedule of Equity Method Investments [Line Items]                      
Revenues         42,965       84,367    
Cost of revenues         10,223       20,515    
Synchronoss Technologies, Inc. | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Net loss attributable to investees         2,341       $ (32,660)    
Other Equity Investments                      
Schedule of Equity Method Investments [Line Items]                      
Current assets 20,514   20,514     20,514         215,927
Noncurrent assets 129,902   129,902     129,902         572,628
Current liabilities 18,797   18,797     18,797         86,672
Noncurrent liabilities 70,553   70,553     70,553         105,711
Revenues     18,500   109,929   30,223 255,903      
Cost of revenues     2,003   79,033   4,797 206,381      
Other Equity Investments | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee 61,066   61,066     61,066         $ 596,172
Net loss attributable to investees     6,323   $ (5,469)   $ 4,009 $ (15,974)      
GA Holdings                      
Schedule of Equity Method Investments [Line Items]                      
Current assets 46,852   46,852     46,852          
Noncurrent assets 286,144   286,144     286,144          
Current liabilities 41,026   41,026     41,026          
Noncurrent liabilities 279,097   279,097     279,097          
Revenues     37,062     58,736          
Cost of revenues     33,044     51,228          
GA Holdings | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee 12,873   12,873     12,873          
Net loss attributable to investees     4,018     7,508          
Joann Retail                      
Schedule of Equity Method Investments [Line Items]                      
Current assets 66,054   66,054     66,054          
Noncurrent assets 20,925   20,925     20,925          
Current liabilities 77,594   77,594     77,594          
Cost of revenues 3,615                    
Joann Retail | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee 9,385   $ 9,385     $ 9,385          
Net loss attributable to investees $ (3,615)